GB0808834D0 - Biomarkers for depression - Google Patents

Biomarkers for depression

Info

Publication number
GB0808834D0
GB0808834D0 GBGB0808834.6A GB0808834A GB0808834D0 GB 0808834 D0 GB0808834 D0 GB 0808834D0 GB 0808834 A GB0808834 A GB 0808834A GB 0808834 D0 GB0808834 D0 GB 0808834D0
Authority
GB
United Kingdom
Prior art keywords
late
depression
onset depression
biomarkers
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0808834.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Priority to GBGB0808834.6A priority Critical patent/GB0808834D0/en
Publication of GB0808834D0 publication Critical patent/GB0808834D0/en
Priority to CN2009801283679A priority patent/CN102099492A/zh
Priority to EP09745831A priority patent/EP2281066A2/en
Priority to PCT/EP2009/055943 priority patent/WO2009138499A2/en
Priority to JP2011508937A priority patent/JP2011523636A/ja
Priority to US12/991,916 priority patent/US20110064655A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
GBGB0808834.6A 2008-05-15 2008-05-15 Biomarkers for depression Ceased GB0808834D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB0808834.6A GB0808834D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression
CN2009801283679A CN102099492A (zh) 2008-05-15 2009-05-15 抑郁症的生物标记
EP09745831A EP2281066A2 (en) 2008-05-15 2009-05-15 Biomarkers for depression
PCT/EP2009/055943 WO2009138499A2 (en) 2008-05-15 2009-05-15 Biomarkers for depression
JP2011508937A JP2011523636A (ja) 2008-05-15 2009-05-15 うつ病に関するバイオマーカー
US12/991,916 US20110064655A1 (en) 2008-05-15 2009-05-15 Biomarkers for depression

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0808834.6A GB0808834D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression

Publications (1)

Publication Number Publication Date
GB0808834D0 true GB0808834D0 (en) 2008-06-18

Family

ID=39571408

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0808834.6A Ceased GB0808834D0 (en) 2008-05-15 2008-05-15 Biomarkers for depression

Country Status (6)

Country Link
US (1) US20110064655A1 (https=)
EP (1) EP2281066A2 (https=)
JP (1) JP2011523636A (https=)
CN (1) CN102099492A (https=)
GB (1) GB0808834D0 (https=)
WO (1) WO2009138499A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808832D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
US9920371B2 (en) 2011-09-22 2018-03-20 Medvet Sciences Pty. Ltd. Screening method
CN103571849B (zh) * 2012-08-06 2015-05-13 北京市理化分析测试中心 用于检测抑郁症的基因及其检测方法和试剂盒
CN105177117A (zh) * 2015-07-03 2015-12-23 张理义 重症抑郁障碍生物标记物、筛选方法及试剂盒
KR102047479B1 (ko) * 2018-01-24 2019-11-21 전남대학교산학협력단 노년기우울증 검출방법 및 진단키트
CN113444802B (zh) * 2021-07-01 2024-02-06 复旦大学附属肿瘤医院 Htr1a在乳腺癌诊断、治疗和预后中的应用
WO2024215722A1 (en) * 2023-04-10 2024-10-17 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing and treating depression and suicide risk

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247442B1 (en) * 1998-05-12 2007-07-24 Human Genome Sciences, Inc. Antibodies to HHPEN62 polypeptide
WO2004047727A2 (en) * 2002-11-01 2004-06-10 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for diagnosing and treating mood disorders
US20050209181A1 (en) * 2003-11-05 2005-09-22 Huda Akil Compositions and methods for diagnosing and treating mental disorders
DK1766077T3 (da) * 2004-06-21 2012-07-16 Univ Leland Stanford Junior Differentielt udtrykte gener og veje i bipolar forstyrrelse og/eller alvorlig depressiv forstyrrelse
WO2008020435A2 (en) * 2006-08-15 2008-02-21 Quark Pharmaceuticals, Inc Compositions and methods for treatment of mood disorders
GB0808833D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression
GB0808832D0 (en) * 2008-05-15 2008-06-18 Ge Healthcare Ltd Biomarkers for depression

Also Published As

Publication number Publication date
US20110064655A1 (en) 2011-03-17
WO2009138499A3 (en) 2010-02-25
WO2009138499A2 (en) 2009-11-19
EP2281066A2 (en) 2011-02-09
JP2011523636A (ja) 2011-08-18
CN102099492A (zh) 2011-06-15

Similar Documents

Publication Publication Date Title
GB0808834D0 (en) Biomarkers for depression
GB0808832D0 (en) Biomarkers for depression
WO2008125651A3 (en) Biomarkers for multiple sclerosis
WO2009153775A3 (en) Methods for distinguishing between specific types of lung cancers
EP3296406A3 (en) Mirna fingerprint in the diagnosis of lung cancer
WO2010062377A3 (en) Methods and compositions for the detection and treatment of preeclampsia
WO2011031786A3 (en) Compositions and methods for diagnosing autism spectrum disorders
WO2010099161A8 (en) Micrornas in never-smokers and related materials and methods
WO2011087760A3 (en) Processes and kits for identifying aneuploidy
WO2013003350A3 (en) Microrna biomarkers indicative of alzheimer's disease
WO2008097277A3 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
WO2009117421A3 (en) Heterocyclic modulators of gpr119 for treatment of disease
WO2007146057A3 (en) Screening method for modulators of viral transcription or replication
WO2006110783A3 (en) Process for making (s)-pregabalin
WO2009120712A3 (en) Compositions and methods for diagnosing and treating melanoma
WO2009156179A8 (en) Her3 as a determinant for the prognosis of melanoma
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
WO2007047408A3 (en) Promac signature application
SA112330754B1 (ar) طريقة تشخيصية للكشف عن مرض قلبي وعائي
WO2012167086A3 (en) Methods of diagnosing and treating amyotrophic lateral sclerosis
GB0808833D0 (en) Biomarkers for depression
WO2007100777A3 (en) Methods for the treatment of adhd and related disorders
WO2011143575A3 (en) smFRET WITH MEMBRANE PROTEINS
WO2010046648A3 (en) Diagnostic test for streptococcus equi
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)